Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH)

Pharmaceutical Preparations

https://www.shuttlepharma.com

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

401 PROFESSIONAL DRIVE, SUITE 260
GAITHERSBURG, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/31/2022

Market Cap

4,513,418

Shares Outstanding

16,000,000

Weighted SO

15,999,125

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

LFCR --.--%

CTLT --.--%

LSDI --.--%

TLRY --.--%

MNK --.--%

ORGO --.--%

ALIM --.--%

DERM --.--%

AKAN --.--%

Beta

1.0570

Last Div

0.0000

Range

1.84-6.4744

Chg

0.0599

Avg Vol

44625

Mkt Cap

4513418

Exch

NASDAQ

Country

US

Phone

240 403 4212

DCF Diff

1.3667

DCF

0.7983

Div Yield

0.0000

P/S

467.4211

EV Multiple

-0.7738

P/FV

12.9022

Div Yield %

0.0000

P/E

-4.8484

PEG

0.0045

Payout

0.0000

Current Ratio

2.9072

Quick Ratio

2.9072

Cash Ratio

0.9392

DSO

452.2432

DIO

0.0504

Op Cycle

452.2936

DPO

17533.9240

CCC

-17081.6304

Gross Margin

0.2507

Op Margin

-593.6669

Pretax Margin

-761.0457

Net Margin

-761.0457

Eff Tax Rate

-0.1020

ROA

-1.5458

ROE

-1.5181

ROCE

-1.7559

NI/EBT

1.0000

EBT/EBIT

1.2819

EBIT/Rev

-593.6669

Debt Ratio

0.2702

D/E

0.4652

LT Debt/Cap

0.0946

Total Debt/Cap

0.3175

Int Coverage

-2.4036

CF/Debt

-4.2678

Equity Multi

1.7215

Rec Turnover

0.8071

Pay Turnover

0.0208

Inv Turnover

7235.0000

FA Turnover

0.0282

Asset Turnover

0.0020

OCF/Share

-0.3308

FCF/Share

-0.3308

Cash/Share

0.2527

OCF/Sales

-567.7556

FCF/OCF

1.0000

CF Coverage

-4.2678

ST Coverage

-5.5045

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

12.9022

P/B

12.9022

P/S

467.4211

P/E

-4.8484

P/FCF

-0.8233

P/OCF

-6.4990

P/CF

-6.4990

PEG

0.0045

P/S

467.4211

EV Multiple

-0.7738

P/FV

12.9022

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 13, 22:00 Shuttle Pharma Provides Third Quarter 2024 Corporate Update Benzinga Oct 30, 01:05 Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules GlobeNewswire Inc. Oct 30, 01:05 Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules Investing.com Jul 20, 02:42 Shuttle Pharma reports progress in breast cancer treatment By Investing.com - Investing.com Canada

Revenue Product Segmentation